MTOR and neoplasm: (38) demonstrated that cholesterol-rich membrane domains can stabilize PD-L1 on tumor cells, activate the PI3K/AKT/mTOR signaling pathway, and promote the expression and stability of downstream target protein HIF-1α through this pathway, thereby inhibiting CD8+ T cell activity and promoting immune escape.